HK1016492A1 - Fast disintegrating oral dosage form. - Google Patents

Fast disintegrating oral dosage form.

Info

Publication number
HK1016492A1
HK1016492A1 HK99101582A HK99101582A HK1016492A1 HK 1016492 A1 HK1016492 A1 HK 1016492A1 HK 99101582 A HK99101582 A HK 99101582A HK 99101582 A HK99101582 A HK 99101582A HK 1016492 A1 HK1016492 A1 HK 1016492A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
pct
date oct
oral dosage
sec
Prior art date
Application number
HK99101582A
Other languages
English (en)
Inventor
Pierre Humbet-Droz
Matthias Seidel
Rosa Martani
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of HK1016492A1 publication Critical patent/HK1016492A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK99101582A 1996-04-16 1999-04-13 Fast disintegrating oral dosage form. HK1016492A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16
PCT/EP1997/001696 WO1997038679A2 (fr) 1996-04-16 1997-04-04 Forme galenique orale se desintegrant rapidement

Publications (1)

Publication Number Publication Date
HK1016492A1 true HK1016492A1 (en) 1999-11-05

Family

ID=8225590

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101582A HK1016492A1 (en) 1996-04-16 1999-04-13 Fast disintegrating oral dosage form.

Country Status (13)

Country Link
US (1) US6083531A (fr)
EP (1) EP0893992B1 (fr)
JP (1) JP2000508649A (fr)
AT (1) ATE260646T1 (fr)
AU (1) AU2636797A (fr)
DE (1) DE69727922T2 (fr)
DK (1) DK0893992T3 (fr)
ES (1) ES2217410T3 (fr)
HK (1) HK1016492A1 (fr)
PT (1) PT893992E (fr)
TR (1) TR199802068T2 (fr)
WO (1) WO1997038679A2 (fr)
ZA (1) ZA973190B (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2178876T5 (es) * 1998-03-06 2012-10-01 Aptalis Pharma S.R.L. Pastilla de desintegración rápida
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
WO2000030616A1 (fr) * 1998-11-20 2000-06-02 Rtp Pharma Inc. Microparticules dispersibles stabilisees par phospholipides
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
CA2380449A1 (fr) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Forme galenique a dissolution rapide et procede de fabrication associe
YU96602A (sh) * 2000-06-27 2005-03-15 F.Hoffmann-La Roche Ag. Postupak za spravljanje smeše
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (fr) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
AU2003211051A1 (en) * 2002-02-13 2003-09-04 Michael K. Weibel Drug dose-form and method of manufacture
FI3473251T3 (fi) 2002-12-20 2024-01-09 Niconovum Ab Nikotiini-selluloosa-kombinaatio
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
PT1667664T (pt) * 2003-09-24 2016-11-21 Novartis Consumer Health Sa Comprimidos revestidos de diclofenac
WO2005044006A1 (fr) * 2003-11-05 2005-05-19 Battelle Memorial Institute Dissolution rapide de produits agrochimiques
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
CA2566793C (fr) 2004-05-11 2013-07-16 Egalet A/S Nouvelle forme de dosage
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US7992575B2 (en) * 2005-02-28 2011-08-09 U.S. Smokeless Tobacco Company Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines
IS7724A (is) 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
KR100702069B1 (ko) 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CA2673458A1 (fr) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Comprimes a desintegration par voie orale contenant une dose elevee de principes actifs: composition utilisee et methodes de fabrication
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US9271524B1 (en) 2007-09-07 2016-03-01 U.S. Smokeless Tobacco Company Tobacco having reduced tobacco specific nitrosamine content
BRPI0819231B8 (pt) 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
CN103751091B (zh) * 2008-02-28 2017-08-25 R·P·舍勒科技有限责任公司 使多晶型现象最小化的方法
EP2133071A1 (fr) * 2008-06-09 2009-12-16 Université de la Méditerranée Procédé pour fabriquer des formes de dosage de rétention gastrique
FR2933959B1 (fr) * 2008-07-16 2010-09-10 Roquette Freres Procede de fabrication de films directement en alveole.
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
JP5676134B2 (ja) 2009-04-22 2015-02-25 メドスキン ソリューションズ ドクター ズベラック アーゲーＭｅｄＳｋｉｎ Ｓｏｌｕｔｉｏｎｓ Ｄｒ．Ｓｕｗｅｌａｃｋ ＡＧ 凍結乾燥成形品およびそれを使用する方法、並びにそのパーツキット製品
BRPI1012170A2 (pt) * 2009-05-20 2016-03-29 Lingual Consegna Pty Ltd formulação e/ou sublingual e método para reduzir a quantidade de composto ativo usado para alcançar um efeito em um paciente em comparação com um composto típico que é ingerido.
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8343533B2 (en) * 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CN103140218A (zh) * 2010-09-22 2013-06-05 麦克内尔-Ppc股份有限公司 多层口腔崩解片剂及其制造
WO2012039789A1 (fr) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Fabrication de formes pharmaceutiques à densité variable utilisant l'énergie de radiofréquence
BR112013006689A2 (pt) * 2010-09-22 2016-06-07 Mcneil Ppc Inc fabricação de tabletes a partir de blenda de pós com energia aplicada
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
WO2014007779A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
WO2014007780A1 (fr) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations de dexkétoprofène à désintégration orale
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
JP6505721B2 (ja) 2014-01-10 2019-04-24 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド 高周波及び損失性被覆粒子を使用した錠剤の製造プロセス
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
AU2021370820A1 (en) * 2020-10-30 2023-06-01 Dsm Ip Assets B.V. Non-effervescent dissolvable tablets comprising hmos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
EP0491754A4 (en) * 1989-09-15 1992-08-12 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
EP0494972B1 (fr) * 1989-10-02 1996-11-27 Cima Labs, Inc. Presentation sous forme effervescente d'un medicament a usage pediatrique
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
KR100256147B1 (ko) * 1991-12-24 2000-08-01 오노다 마사요시 구강내 붕해성 제제 및 이의 제조방법
WO1993015724A1 (fr) * 1992-02-18 1993-08-19 Nippon Shinyaku Co., Ltd. Comprime a solubilite acceleree
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
SK91096A3 (en) * 1994-01-27 1997-06-04 Univ Oklahoma Board Of Rapidly dissolving oral dosage form
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
EP0893992B1 (fr) 2004-03-03
AU2636797A (en) 1997-11-07
DE69727922T2 (de) 2005-01-20
DE69727922D1 (de) 2004-04-08
EP0893992A2 (fr) 1999-02-03
WO1997038679A2 (fr) 1997-10-23
ATE260646T1 (de) 2004-03-15
US6083531A (en) 2000-07-04
ZA973190B (en) 1997-12-17
DK0893992T3 (da) 2004-06-01
WO1997038679A3 (fr) 1997-12-04
JP2000508649A (ja) 2000-07-11
TR199802068T2 (xx) 2000-01-21
ES2217410T3 (es) 2004-11-01
PT893992E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
HK1016492A1 (en) Fast disintegrating oral dosage form.
AU1537095A (en) Therapeutic agents containing thyroid hormones
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
YU39400A (sh) Kombinacije opijatni agonist/antagonist
BG105534A (en) 5ht1 means and method for the treatment of migraine
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AU3608295A (en) Process of making dosage units by wet granulation
IL108234A0 (en) Pharmaceutical composition containing galanthamine
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
GB9317636D0 (en) Use of dexmedetomidine
GB9424766D0 (en) Pharmaceutical composition
IL124091A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the preparation of pharmaceutical compositions for the treatment of amyotrophic lateral sclerosis and pharmaceutical compositions containing it
NZ292429A (en) Combination of non-narcotic analgesic and nmda receptor antagonist for alleviating pain
PL348202A1 (en) Pharmaceutically active composition and dispensing device
IL122659A (en) Pharmaceutical compositions for the treatment of dyspeptic symptoms comprising angiotensin ii type receptor antagonists
GR3030954T3 (en) Children-proof package for active substance-containing plaster
GEP20043377B (en) Pharmaceutical Complex
MY127600A (en) Solid oral dosage forms of valsartan

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130404